Table 3:
Association with age of disease onset | Association with disease duration | ||||
---|---|---|---|---|---|
Haplotype | Haplotype frequency (%), N=309 | β (95% CI) | P-value | β (95% CI) | P-value |
H1b | 13.3% | 2.66 (0.63, 4.70) | 0.011 | −0.03 (−1.07, 1.02) | 0.96 |
H1c | 10.0% | 1.63 (−0.61, 3.86) | 0.15 | 0.08 (−1.05, 1.22) | 0.88 |
H1d | 7.2% | 0.79 (−1.79, 3.38) | 0.55 | −0.91 (−2.21, 0.39) | 0.17 |
H1e | 9.3% | 0.52 (−1.94, 2.98) | 0.68 | 0.52 (−0.72, 1.76) | 0.41 |
H1h | 4.0% | 2.03 (−1.57, 5.64) | 0.27 | −0.45 (−2.27, 1.37) | 0.63 |
H1i | 4.1% | −3.66 (−6.83, −0.48) | 0.025 | −0.90 (−2.53, 0.72) | 0.28 |
H1l | 3.5% | −1.75 (−5.42, 1.92) | 0.35 | 0.43 (−1.42, 2.28) | 0.65 |
H1m | 3.1% | −1.25 (−5.33, 2.84) | 0.55 | 0.94 (−1.11, 3.00) | 0.37 |
H1o | 1.2% | 0.05 (−6.91, 7.00) | 0.99 | 0.03 (−3.47, 3.52) | 0.99 |
H1p | 1.0% | −5.65 (−12.60, 1.30) | 0.11 | 0.17 (−3.36, 3.69) | 0.93 |
H1u | 2.2% | −5.25 (−10.42, −0.07) | 0.048 | −2.40 (−5.03, 0.22) | 0.074 |
H1v | 2.1% | −1.74 (−6.61, 3.13) | 0.48 | 1.91 (−0.54, 4.35) | 0.13 |
H1x | 1.4% | −5.39 (−11.84, 1.07) | 0.10 | −3.73 (−6.98, −0.48) | 0.025 |
H1y | 1.5% | −0.70 (−6.93, 5.54) | 0.83 | 1.82 (−1.31, 4.95) | 0.26 |
H1z | 1.6% | −1.81 (−8.02, 4.40) | 0.57 | −0.08 (−3.20, 3.05) | 0.96 |
H2 | 29.4% | −0.62 (−2.03, 0.79) | 0.39 | 0.22 (−0.49, 0.93) | 0.54 |
β values, 95% CIs, and p-values result from score tests of association that were adjusted for sex and series (age of disease onset analysis) or sex, age of disease onset, and series (disease duration analysis). β values are interpreted as the change in the mean value of the given outcome (age of disease onset or disease duration) corresponding to each additional copy of the given haplotype. P-values <0.0031 are considered as statistically significant after applying a Bonferroni correction for multiple testing. β=regression coefficient; CI=confidence interval.